TVRD

NASDAQ · Pharmaceuticals

Tvardi Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.87

+0.02 (+1.08%)

As of Aug 8, 10:50 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 64%

Hold 4 29%

Sell 1 7%

Price Target

Analyst Price Target +1,935.8% upside

Low Target $23.38

Average Target $38.07

High Target $43.34

Current Price $1.87

Current
$1.87

Target
$38.07

$23.38 $38.07 avg $43.34

Scenario Analysis

Bear Case

$23.38

1,150.3%

Low target

Base Case

$38.07

+1,935.8%

Avg target

Bull Case

$43.34

+2,217.6%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$43.65

-95.7% from high

52-Week Low

$1.50

+24.7% from low

Target vs 52W High

$38.07

-12.8% vs high

Next Earnings Report

Aug 13, 2026

until earnings

EPS Est: $-0.72

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%